Clinical and Experimental Medical Journal
Volume/Issue:
Volume 4: Issue 1
Pitfalls in management of chronic hepatitis B: Report of four cases from Bangladesh
Authors:
Md. Fazal Karim Department of Hepatology, Dhaka Medical College, Dhaka, Bangladesh

Search for other papers by Md. Fazal Karim in
Current site
Google Scholar
PubMed Close
,
Mamun Al-Mahtab Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Mamun Al-Mahtab in
Current site
Google Scholar
PubMed Close
,
Salimur Rahman Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Salimur Rahman in
Current site
Google Scholar
PubMed Close
, and
Mobin Khan Department of Hepatology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

Search for other papers by Mobin Khan in
Current site
Google Scholar
PubMed Close
Pages:
207–210
Online Publication Date:
01 Mar 2010
Publication Date:
01 Mar 2010
Article Category:
Research Article
DOI:
https://doi.org/10.1556/CEMED.4.2010.1.22
Keywords:
chronic hepatitis B; management; pitfalls
Restricted access

Abstract

Treatment of chronic hepatitis B has changed much since the introduction of interferon. Nucleosides have come to replace interferon in some situations like decompensated states. However, there is no clear cut guideline in many fields. Even end of treatment response is low in conventional treatments. This study describes a few scenarios where difficulties were faced. Unresolved questions in the management of chronic hepatitis B involve ‘who to treat, when to treat, how to treat?’ These should be clearly addressed.

  • [1]. L. R. Arosemena R. A. Cortes L. Servin et al.2005 Current and future treatment of chronic hepatitis B Minerva Gastroenterol. Dietol. 51 77–93.

    • Search Google Scholar
    • Export Citation

  • [2]. Dusheiko, G., Antonakopoulos, N.: Treatment of hepatitis B. Gut, published 14 May 2007, DOI 10.1136/gut.2005.077891, PMID: 17502343.

    • Search Google Scholar
    • Export Citation

  • [3]. L. D'Antiga Aw. Marion M. Atkins et al.2006 Combined lamivudine/interferon-α treatment in ‘immunotolerant’ children perinatally infected with hepatitis B: a pilot study J. Pediatr. 148 228–233.

    • Search Google Scholar
    • Export Citation

  • [4]. G. G. Su K. H. Pan N. F. Zhao et al.2004 Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy World J. Gastroenterol. 10 910–912.

    • Search Google Scholar
    • Export Citation

  • [5]. J. H. Hoofnagle E. Doo T. J. Liang et al.2007 Management of hepatitis B: summary of a clinical research workshop Hepatology 45 1056–1075.

    • Search Google Scholar
    • Export Citation

  • [6]. N. Saikia R. Talukdar S. Mazumder et al.2007 Management of patients with HBeAg-negative chronic hepatitis B Postgrad. Med. J. 83 32–39.

    • Search Google Scholar
    • Export Citation

  • [7]. M. Morgan W. Park E. B. Keeffe 2007 Diagnosis and treatment of chronic hepatitis B: an update Minerva Gastroenterol. Dietol. 53 25–41.

    • Search Google Scholar
    • Export Citation

  • [8]. G. J. Dore R. Guan S. M. Wasim Jafri et al.2006 Management of chronic hepatitis B in challenging patient populations Liver Int. 26 Suppl.2 38–46.

    • Search Google Scholar
    • Export Citation

  • [9]. M. F. Yuen C. L. Lai 2007 Combination therapy for chronic hepatitis B: simultaneous or sequential? Am. J. Gastroenterol. 102 105–106.

    • Search Google Scholar
    • Export Citation

  • [10]. A. Ascione T. Ascione A. G. Lanza et al.2006 Factors infl uencing outcome of lamivudine in anti-HBe-positive chronic hepatitis B Hepatogastroenterology 53 919–923.

    • Search Google Scholar
    • Export Citation

  • [11]. J. J. Sasadeusz S. L. Locarnini G. Macdonald 2007 Why do we not yet have combination chemotherapy for chronic hepatitis B Med. J. Aust. 186 204–206.

    • Search Google Scholar
    • Export Citation
  • Collapse
  • Expand
Cover Clinical and Experimental Medical Journal
Clinical and Experimental Medical Journal
Print ISSN:
2060-6249
Online ISSN:
2060-968X

Clinical and Experimental Medical Journal
Language English
Size  
Year of
Foundation		 2007
Publication
Programme		 ceased
Volumes
per Year		  
Issues
per Year		  
Publisher Akadémiai Kiadó
Publisher's
Address		 H-1117 Budapest, Hungary 1516 Budapest, PO Box 245
Responsible
Publisher		 Chief Executive Officer, Akadémiai Kiadó
ISSN 2060-6249 (Print)
ISSN 2060-968X (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Aug 2024 30 0 0
Sep 2024 21 0 0
Oct 2024 43 0 0
Nov 2024 14 0 0
Dec 2024 4 0 0
Jan 2025 4 0 0
Feb 2025 0 0 0